Trial 4P-15-3


ARMOR3-SV: A Phase 3, Randomized, Open Label, Multi- Center Controlled Study of Galeterone Compared to Enzalutamide in Men Expressing Androgen Receptor Splice Variant-7 mRNA(AR-V7) Metastatic (M1) Castrate Resistant Prostate Cancer (CRPC)

Type: Treatment
Phase: Phase III
Status: Not Open (Closed)
Treatments: Hormone
Randomized: Yes
USC Satellite Location: None
Defintions of terms and FAQ about clinical trials.
Trial Leaders/Researchers:  David Quinn, M.D.
Other Trial Staff:  Lagrimas Ilagan, D.M., Roberto Tejada, D.M., Jessica Levano, R.N., Olga Castellanos, Coordinator, Taison Tran, Coordinator, Yvette Viverette, R.N., Elysse Faye Ballon, Coordinator

Staff may log in to see study documents.

Click here to see trial eligibility criteria and further details at ClinicalTrials.gov





For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or clinical.trials@med.usc.edu.

To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3300.